Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.44 |
| ▸ | GPR3 | P46089 | 5/20 | 0.42 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.39 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29954255 | 1.00 | PDE2A (0.44) | PDE2AGPR3CXCR2CXCR1FFAR4 | |
| SCHEMBL2683035 | 0.90 | EPHX2 (0.38) | PDE2AGPR3MAPTEPHX2L3MBTL1 | |
| SCHEMBL257606 | 0.89 | F10 (0.42) | PDE2AGPR3 | |
| SCHEMBL18708406 | 0.88 | PDE2A (0.41) | PDE2AGPR3CXCR2FFAR4MAPT | |
| SCHEMBL257822 | 0.85 | GPR3 (0.42) | PDE2AGPR3CXCR2FFAR4ABL1 | |
| SCHEMBL28961819 | 0.83 | GPR3 (0.43) | GPR3CXCR2ABL1MAPTEPHX2 | |
| SCHEMBL769093 | 0.81 | GPR3 (0.42) | GPR3CXCR2FFAR4ABL1MAPT | |
| SCHEMBL3139123 | 0.81 | GPR3 (0.42) | PDE2AGPR3CXCR2CXCR1ABL1 | |
| SCHEMBL29392559 | 0.81 | GPR3 (0.42) | GPR3CXCR2FFAR4ABL1MAPT | |
| SCHEMBL14125444 | 0.81 | SLC6A4 (0.39) | FFAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388585-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12448388-B2 | PRMT5 inhibitors and uses thereof | GILEAD SCIENCES, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250074881-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2025-03-06 | — | — | US | disclosed |
| US-20240376110-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES, INC. | 2024-11-14 | — | — | US | disclosed |
| WO-2024220917-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2024-10-24 | — | — | WO | disclosed |
| US-12110276-B2 | Pyrazolo compounds and methods of use thereof | GENENTECH, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| EP-4436957-A1 | THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER | Genentech, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-118302411-A | Therapeutic indazole compounds and methods of use thereof for the treatment of cancer | 基因泰克公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240059677-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | CEREVANCE LTD (GB) | 2024-02-22 | — | — | US | disclosed |
| CN-111936503-B | Oxazine monoacylglycerol lipase (MAGL) inhibitors | 豪夫迈·罗氏有限公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2009004430-A1 | N-BENZYL OXAZOLIDINONES AND RELATED HETEROCYCLEIC COMPOUNDS AS POTENTIATORS OF GLUTAMATE RECEPTORS | PFIZER INC. (US) | 2009-01-08 | — | — | WO | disclosed |
| EP-1425278-B1 | INSECTICIDAL 3-(2,6-DISUBSTITUTED PHENYL)-5- 4- OR 5-ARYLTHIEN-2- OR -3-YL|-1,2,4-TRIAZOLES | DOW AGROSCIENCES LLC (US) | 2006-12-20 | — | — | EP | disclosed |
| US-7056940-B2 | Insecticidal 3-(2,6-disubstituted phenyl)-5-[5-arylthien-2-yl]-1,2,4-triazoles | DOW AGROSCIENCES LLC (US) | 2006-06-06 | — | — | US | disclosed |
| US-6949576-B2 | Insecticidal 3-(2,6-disubstituted phenyl)-5-[5-arylthien-3-yl]-1,2,4-triazoles | DOW AGROSCIENCES LLC (US) | 2005-09-27 | — | — | US | disclosed |
| US-20040171661-A1 | Insecticidal 3-(2,6-disubstituted phenyl)-5-[5-arylthien-2-yl]-1,2,4-triazoles | HEGDE VIDYADHAR BABU (US) | 2004-09-02 | — | — | US | disclosed |
| US-6770665-B2 | TRIAZOLE COMPOUNDS HAVING A 2,6-DISUBSTITUTED-PHENYL GROUP IN THE 3-POSITION, ARYLTHIEN-2- OR -3-YL IN THE 5-POSITION AND AN ALKYL GROUP IN THE 1-POSITION ARE EFFECTIVE IN CONTROLLING LEPIDOPTERA, COLEOPTERA, MITES AND OTHER SUCKING PESTS. | DOW AGROSCIENCES LLC | 2004-08-03 | — | — | US | disclosed |
| EP-1425278-A1 | INSECTICIDAL 3-(2,6-DISUBSTITUTED PHENYL)-5- 4- OR 5-ARYLTHIEN-2- OR -3-YL]-1,2,4-TRIAZOLES | Dow Agrosciences LLC (US) | 2004-06-09 | — | — | EP | disclosed |
| US-20040072887-A1 | Insecticidal 3-(2,6-disubstituted phenyl)-5-[5-arylthien-3-yl]-1,2,4-triazoles | HEGDE VIDYADHAR BABU (US) | 2004-04-15 | — | — | US | disclosed |
| US-20030134748-A1 | Insecticial 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles | DOW AGROSCIENCES LLC | 2003-07-17 | — | — | US | disclosed |
| WO-2003024961-A1 | INSECTICIDAL 3-(2,6-DISUBSTITUTED PHENYL)-5-[4- OR 5-ARYLTHIEN-2- OR -3-YL]-1,2,4-TRIAZOLES | DOW AGROSCIENCES LLC (US) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388585-A1 | PRMT5 INHIBITORS AND USES THEREOF | PRMT1, PRMT5, PRMT6 | PDE2A 1640/4885GPR3 2962/4885CXCR2 2558/4885 |
| US-20250074881-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE | VHL, TP53, MCL1 | PDE2A 1863/4885GPR3 4296/4885CXCR2 1166/4885 |
| US-20040171661-A1 | Insecticidal 3-(2,6-disubstituted phenyl)-5-[5-arylthien-2-yl]-1,2,4-triazoles | L3MBTL3, API5, L3MBTL4 | PDE2A 997/4885GPR3 236/4885CXCR2 3427/4885 |
| US-20240376110-A1 | PRMT5 INHIBITORS AND USES THEREOF | PRMT5, PRMT1, PRMT9 | PDE2A 856/4885GPR3 4118/4885CXCR2 4304/4885 |
| US-20240059677-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | CHRNA6, CHRM2, CHRNA1 | PDE2A 359/4885GPR3 115/4885CXCR2 519/4885 |
| US-12448388-B2 | PRMT5 inhibitors and uses thereof | PRMT5, PRMT1, PRMT9 | PDE2A 856/4885GPR3 4118/4885CXCR2 4304/4885 |
| US-20040072887-A1 | Insecticidal 3-(2,6-disubstituted phenyl)-5-[5-arylthien-3-yl]-1,2,4-triazoles | L3MBTL3, API5, L3MBTL4 | PDE2A 1012/4885GPR3 185/4885CXCR2 3607/4885 |
| US-20030134748-A1 | Insecticial 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles | L3MBTL3, API5, L3MBTL4 | PDE2A 1826/4885GPR3 198/4885CXCR2 2923/4885 |
| US-12110276-B2 | Pyrazolo compounds and methods of use thereof | THPO, KLK3, TP53 | PDE2A 535/4885GPR3 3146/4885CXCR2 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.